The pattern marked A in the diagram represents the restrictive physiology characteristic of idiopathic pulmonary fibrosis (IPF). According to the ATS/ERS/JRS/ALAT 2022 IPF Guideline and INPULSIS trials, IPF presents with a restrictive defect showing reduced FVC and TLC with a preserved or elevated FEV1/FVC ratio (typically >0.80). Critically, DLCO is disproportionately reduced out of proportion to lung volumes, reflecting the alveolar membrane destruction and epithelial-capillary injury that characterizes UIP histology. This disproportionate DLCO reduction is a hallmark physiological finding in IPF and helps distinguish it from other restrictive diseases.
ATS/ERS/JRS/ALAT IPF Guideline 2022; INPULSIS NEJM 2014
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.